A Study of the Effectiveness of Different Anti-HIV Treatments in HIV-Positive Individuals Who Have Been on a Protease Inhibitor-Containing Drug Regimen for at Least 16 Weeks

NACompletedINTERVENTIONAL
Enrollment

800

Participants

Timeline

Start Date

Not specified

Study Completion Date

June 30, 2000

Conditions
HIV Infections
Interventions
DRUG

Indinavir sulfate

DRUG

Ritonavir

DRUG

Nelfinavir mesylate

DRUG

Efavirenz

Trial Locations (15)

10037

Harlem AIDS Treatment Grp / Harlem Hosp Ctr, New York

19107

Philadelphia FIGHT, Philadelphia

20422

Washington Reg AIDS Prog / Dept of Infect Dis, Washington D.C.

48201

Wayne State Univ - WSU/DMC / Univ Hlth Ctr, Detroit

48202

Henry Ford Hosp, Detroit

60657

AIDS Research Alliance - Chicago, Chicago

70112

Louisiana Comm AIDS Rsch Prog / Tulane Univ Med, New Orleans

87131

Partners in Research / New Mexico, Albuquerque

94110

Community Consortium / UCSF, San Francisco

97210

The Research and Education Group, Portland

232980049

Richmond AIDS Consortium / Div of Infect Diseases, Richmond

303081962

AIDS Research Consortium of Atlanta, Atlanta

802044507

Denver CPCRA / Denver Public Hlth, Denver

08103

Southern New Jersey AIDS Cln Trials / Dept of Med, Camden

071032842

North Jersey Community Research Initiative, Newark

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00000914 - A Study of the Effectiveness of Different Anti-HIV Treatments in HIV-Positive Individuals Who Have Been on a Protease Inhibitor-Containing Drug Regimen for at Least 16 Weeks | Biotech Hunter | Biotech Hunter